Pascal André

1.5k total citations
41 papers, 1.1k citations indexed

About

Pascal André is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Pascal André has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 14 papers in Psychiatry and Mental health and 13 papers in Oncology. Recurrent topics in Pascal André's work include Pharmacological Effects and Toxicity Studies (15 papers), Epilepsy research and treatment (14 papers) and Drug Transport and Resistance Mechanisms (12 papers). Pascal André is often cited by papers focused on Pharmacological Effects and Toxicity Studies (15 papers), Epilepsy research and treatment (14 papers) and Drug Transport and Resistance Mechanisms (12 papers). Pascal André collaborates with scholars based in Switzerland, France and United Kingdom. Pascal André's co-authors include Salvatore Cisternino, Thierry Buclin, Laurent A. Décosterd, Jean‐Michel Scherrmann, Marcel Debray, Bruno Saubaméa, Jean‐François Eliaou, Andrea O. Rossetti, Odile Avinens and Jacques Clot and has published in prestigious journals such as Annals of Neurology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Pascal André

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal André Switzerland 19 249 231 216 196 189 41 1.1k
Philippe Jacqmin Belgium 20 195 0.8× 253 1.1× 242 1.1× 70 0.4× 321 1.7× 57 1.5k
Olivier Tribut France 19 138 0.6× 184 0.8× 130 0.6× 123 0.6× 298 1.6× 48 1.4k
Brian Granda United States 18 261 1.0× 446 1.9× 825 3.8× 110 0.6× 287 1.5× 26 1.9k
Charles Locke United States 20 156 0.6× 192 0.8× 95 0.4× 234 1.2× 347 1.8× 54 1.4k
Ronald Gieschke Switzerland 21 81 0.3× 304 1.3× 277 1.3× 70 0.4× 150 0.8× 47 1.5k
Andrés Navarro‐Ruiz Spain 18 162 0.7× 282 1.2× 57 0.3× 62 0.3× 156 0.8× 75 1.3k
Stéphanie Chhun France 14 207 0.8× 109 0.5× 124 0.6× 39 0.2× 194 1.0× 34 792
Ka Lai Yee United States 21 170 0.7× 179 0.8× 167 0.8× 215 1.1× 429 2.3× 51 1.3k
Scott Q. Siler United States 19 107 0.4× 275 1.2× 262 1.2× 131 0.7× 77 0.4× 30 1.4k
Carlo Tomino Italy 19 53 0.2× 195 0.8× 59 0.3× 106 0.5× 243 1.3× 70 1.2k

Countries citing papers authored by Pascal André

Since Specialization
Citations

This map shows the geographic impact of Pascal André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal André more than expected).

Fields of papers citing papers by Pascal André

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal André. The network helps show where Pascal André may publish in the future.

Co-authorship network of co-authors of Pascal André

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal André. A scholar is included among the top collaborators of Pascal André based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal André. Pascal André is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choong, Eva, Pascal André, Andrea O. Rossetti, et al.. (2025). Is the salivary concentration of lamotrigine and levetiracetam associated with clinical outcome?. Epilepsy & Behavior. 171. 110595–110595.
2.
André, Pascal, Yann Thoma, Nicolas Widmer, et al.. (2023). Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective. Pharmaceutics. 15(4). 1283–1283. 15 indexed citations
3.
Desfontaine, Vincent, Katharina Kusejko, Perrine Courlet, et al.. (2023). Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration. Journal of Antimicrobial Chemotherapy. 78(6). 1433–1443. 2 indexed citations
4.
Munting, Aline, Matthias Cavassini, Dominique L. Braun, et al.. (2022). Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland. Pharmaceutics. 14(8). 1588–1588. 10 indexed citations
5.
André, Pascal, et al.. (2022). Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response. European Journal of Neurology. 29(9). 2607–2611. 5 indexed citations
6.
Dao, Kim, Vincent Jullien, Pascal André, et al.. (2022). An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup. Pharmacology Research & Perspectives. 11(1). e01032–e01032. 3 indexed citations
7.
André, Pascal, Kim Dao, Laura E. Rothuizen, et al.. (2022). Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!. Frontiers in Pediatrics. 9. 768438–768438. 10 indexed citations
8.
Desfontaine, Vincent, Sylvie Guinchard, Sara R. Marques, et al.. (2022). Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine. Journal of Chromatography B. 1215. 123555–123555. 6 indexed citations
9.
André, Pascal, et al.. (2021). Seizure freedom and plasma levels of newer generation antiseizure medications. Acta Neurologica Scandinavica. 144(2). 202–208. 10 indexed citations
10.
Dao, Kim, Aline Fuchs, Pascal André, et al.. (2021). Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation. Journal of Antimicrobial Chemotherapy. 77(2). 457–465. 3 indexed citations
11.
André, Pascal, et al.. (2021). Therapeutic drug monitoring of newer generation antiseizure medications at the point of treatment failure. Seizure. 94. 66–69. 3 indexed citations
12.
Buclin, Thierry, Yann Thoma, Nicolas Widmer, et al.. (2020). The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib. Frontiers in Pharmacology. 11. 177–177. 79 indexed citations
13.
Dao, Kim, Monia Guidi, Pascal André, et al.. (2019). Optimisation of vancomycin exposure in neonates based on the best level of evidence. Pharmacological Research. 154. 104278–104278. 34 indexed citations
14.
André, Pascal, et al.. (2018). Levetiracetam circulating concentrations and response in status epilepticus. Epilepsy & Behavior. 88. 61–65. 15 indexed citations
15.
André, Pascal, et al.. (2018). Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response. Epilepsy Research. 149. 88–91. 34 indexed citations
16.
André, Pascal, et al.. (2017). Intravenous lacosamide in status epilepticus: Correlation between loading dose, serum levels, and clinical response. Epilepsy Research. 135. 38–42. 23 indexed citations
17.
Ezan, Pascal, Pascal André, Salvatore Cisternino, et al.. (2012). Deletion of Astroglial Connexins Weakens the Blood–Brain Barrier. Journal of Cerebral Blood Flow & Metabolism. 32(8). 1457–1467. 177 indexed citations
18.
André, Pascal, et al.. (2007). Stability of oxaliplatin in infusion bags containing 5% dextrose injection. American Journal of Health-System Pharmacy. 64(18). 1950–1954. 15 indexed citations
19.
Reynes, Jacques, Pierre Portalès, Michel Segondy, et al.. (2001). CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS. 15(13). 1627–1634. 79 indexed citations
20.
Reynes, Jacques, Pierre Portalès, Michel Segondy, et al.. (2000). CD4+T Cell Surface CCR5 Density as a Determining Factor of Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 181(3). 927–932. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Jacqmin Breakdown of academic impact, for papers by Olivier Tribut Breakdown of academic impact, for papers by Brian Granda Breakdown of academic impact, for papers by Charles Locke Breakdown of academic impact, for papers by Ronald Gieschke Breakdown of academic impact, for papers by Andrés Navarro‐Ruiz Breakdown of academic impact, for papers by Stéphanie Chhun Breakdown of academic impact, for papers by Ka Lai Yee Breakdown of academic impact, for papers by Scott Q. Siler Breakdown of academic impact, for papers by Carlo Tomino
Rankless by CCL
2026